icad inc.

iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier while enhancing patient care. iCAD offers a comprehensive range of  computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast and colorectal cancers. iCAD’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared and CE marked for use anywhere in the body, including treatment of non-melanoma skin cancer, early-stage breast cancer and gynecological cancers. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection and radiation therapy treatments. 

Bank Name icad inc.
Stock Exchange NASDAQ
Symbol ICAD
Sector Technology
Industry Medical/Dental Instruments
Country United States
World Region Amarica
Chairman
CEO Mr. Kenneth M. Ferry
Employees 115
Website www.icadmed.com
Registered Year 1984

UpdateContent
UpdateContent
UpdateContent